TCI Wealth Advisors, Inc. - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 39 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$455
+7.1%
5000.0%0.00%
Q4 2022$425
-57.5%
500
-37.5%
0.00%
Q3 2022$1,0000.0%8000.0%0.00%
Q2 2022$1,0000.0%800
+100.0%
0.00%
Q1 2022$1,0000.0%4000.0%0.00%
Q4 2021$1,0000.0%400
+33.3%
0.00%
Q3 2021$1,0003000.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$11,661,0002.42%
Telemetry Investments, L.L.C. 189,081$673,0001.14%
CHI Advisors LLC 490,877$1,748,0000.49%
BVF INC/IL 1,943,712$6,920,0000.27%
Orbimed Advisors 6,767,584$24,093,0000.21%
Novo Holdings A/S 847,906$3,019,0000.13%
Golden Green, Inc. 19,539$70,0000.06%
ALGERT GLOBAL LLC 15,467$55,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,700$476,0000.01%
Hikari Power Ltd 19,959$71,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders